A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Paroxetine Methoxy Analog - Request Quote

Picture of Paroxetine Methoxy Analog

Paroxetine Methoxy Analog

SZ CAT No:SZ-P012042
CAS No
NA
Mol.F.
C20H23NO4 : HCl
Mol.Wt.
341.4 : 36.5
Inv. Status
Synthesis on demand

Chemical Name :

Shipping Temperature :

HSN Code :

Country of Origin :

Smiles :

Usage Note:

Paroxetine Methoxy Analog is chemically ((3R,4S)-3-((benzo[d][1,3]dioxol-5-yloxy)methyl)-4-(4-methoxyphenyl)piperidine, hydrochloride) (as per USP). Paroxetine Methoxy Analog is supplied with detailed characterization data compliant with regulatory guideline. Paroxetine Methoxy Analog can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Paroxetine.

The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.

Applications & Regulatory Use Cases

buy high quality Paroxetine Methoxy Analog

Purchase Paroxetine Methoxy Analog

Paroxetine Methoxy Analog suppliers

Paroxetine Methoxy Analog manufacturers

Paroxetine Methoxy Analog price

Order Paroxetine Methoxy Analog

Enquire Paroxetine Methoxy Analog

Paroxetine Methoxy Analog cost

Paroxetine Methoxy Analog Supplier

Paroxetine Methoxy Analog Distributor

Paroxetine Methoxy Analog for Method Validation

Paroxetine Reference Standard

Paroxetine Methoxy Analog for ANDA Filing

Paroxetine Methoxy Analog for Forced Degradation Studies

Paroxetine Methoxy Analog Identification Standards

Paroxetine Methoxy Analog for DMF Filing

ℹ️

Disclaimer

SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.

SynZeal will update these details as per new developments or findings in product specifications without further notice.

,